Abstract:BACKGROUND Gestational diabetes mellitus (GDM) is characterized by glucose intolerance that is first diagnosed during pregnancy, making it the most common complication associated with this period. Early detection and targeted treatment of GDM can minimize foetal exposure to maternal hyperglycaemia and subsequently reduce the associated adverse pregnancy outcomes. Previous studies have inconsistently suggested that the level of glycated albumin (GA) might predict GDM. AIM To review and synthesize existing evidence to evaluate the relationship between GA levels and the development of GDM. METHODS We sought to compare GA levels between GDM and control groups in this meta-analysis by systematically searching the Web of Science, PubMed, Cochrane Library, and Embase databases for articles published up to June 2023. The analysis utilized the weighted mean difference (WMD) as the primary metric. The data were meticulously extracted, and the quality of the included studies was assessed. Additionally, we conducted a subgroup analysis based on study region and sample size. We assessed heterogeneity using I 2 statistics and evaluated publication bias through funnel plots. Additionally, trim-and-fill analysis was employed to detect and address any potential publication bias. RESULTS The meta-analysis included a total of 11 studies involving 5477 participants, comprising 1900 patients with GDM and 3577 control individuals. The synthesized results revealed a notable correlation between elevated GA levels and increased susceptibility to GDM. The calculated WMD was 0.42, with a 95% confidence interval (95%CI) ranging from 0.11 to 0.74, yielding a P value less than 0.001. Concerning specific GA levels, the mean GA level in the GDM group was 12.6, while for the control group, it was lower, at 11.6. This discrepancy underscores the potential of GA as a biomarker for assessing GDM risk. Moreover, we explored the levels of glycated haemoglobin (HbA1c) in both cohorts. The WMD for HbA1c was 0.19, with a 95%CI ranging from 0.15 to 0.22 and a P value less than 0.001. This observation suggested that both GA and HbA1c levels were elevated in individuals in the GDM group compared to those in the control group. CONCLUSION Our meta-analysis revealed a substantial correlation between elevated GA levels and increased GDM risk. Furthermore, our findings revealed elevated levels of HbA1c in GDM patients, emphasizing the significance of monitoring both GA and HbA1c levels for early GDM detection and effective management.

Serum Glycated Albumin As Good Biomarker for Predicting Type 2 Diabetes: A Retrospective Cohort Study of China National Diabetes and Metabolic Disorders Survey

An Additional Measurement of Glycated Albumin Can Help Prevent Missed Diagnosis of Diabetes in Chinese Population

[A Multi-Center Clinical Study of the Reference Value of Serum Glycated Albumin].

Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study

Association Between Glycated Albumin and Adverse Outcomes in Patients with Heart Failure.

Combined Assessment of Glycated Albumin and Fasting Plasma Glucose Improves the Detection of Diabetes in Chinese Subjects

Serum glycated albumin predicts the progression of diabetic retinopathy--a five year retrospective longitudinal study.

Postload Glycated Albumin As an Alternate Measure for Diabetes Screening in a Chinese Population

Baseline glycated albumin level and risk of type 2 diabetes mellitus in Healthy individuals: a retrospective longitudinal observation in Korea

Glycated Albumin Level and Its Influential Factors in Type 2 Diabetes Mellitus

Clinical Utility of Glycated Albumin in Type 2 Diabetic Patients

Glycated albumin:an effective marker for assessing glycemic control in diabetic inpatients

Primary Assessment of Enzymatic Measurement of Glycated Albumin

Clinical significance of measurement of glycated albumin in impaired glucose regulation and newly diagnosed diabetes

Circulating glycated albumin levels and gestational diabetes mellitus

Assessment of Glycated Albumin As a Useful Indicator for Renal Dysfunction in Diabetic and Nondiabetic Population.

Association between glycemic control and birthweight with glycated albumin in Chinese women with gestational diabetes mellitus.

Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker

[Combined utility of hemoglobin A1c and glycated albumin in diabetic screening].

Discovery and validation of glucose-sensitive peptide biomarkers from human serum albumin to diagnose type 2 diabetes mellitus

Significance of glycosylated hemoglobin A1c and glycated albumin for the diagnosis of gestational diabetes mellitus